108 related articles for article (PubMed ID: 36863760)
21. The influence of comorbidities on overall survival among older women diagnosed with breast cancer.
Patnaik JL; Byers T; Diguiseppi C; Denberg TD; Dabelea D
J Natl Cancer Inst; 2011 Jul; 103(14):1101-11. PubMed ID: 21719777
[TBL] [Abstract][Full Text] [Related]
22. Moderate to Severe Renal Insufficiency Is Associated With High Mortality After Hip and Knee Replacement.
Jämsä P; Jämsen E; Huhtala H; Eskelinen A; Oksala N
Clin Orthop Relat Res; 2018 Jun; 476(6):1284-1292. PubMed ID: 29601379
[TBL] [Abstract][Full Text] [Related]
23. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer.
Moro-Sibilot D; Aubert A; Diab S; Lantuejoul S; Fourneret P; Brambilla E; Brambilla C; Brichon PY
Eur Respir J; 2005 Sep; 26(3):480-6. PubMed ID: 16135732
[TBL] [Abstract][Full Text] [Related]
24. High Risk of Readmission in Octogenarians Undergoing Primary Hip Arthroplasty.
Malkani AL; Dilworth B; Ong K; Baykal D; Lau E; Mackin TN; Lee GC
Clin Orthop Relat Res; 2017 Dec; 475(12):2878-2888. PubMed ID: 28083755
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer-is interval cytoreductive surgery still needed?
Klein DA; Mann AK; Freeman AH; Liao CI; Kapp DS; Chan JK
Am J Obstet Gynecol; 2020 Feb; 222(2):170.e1-170.e11. PubMed ID: 31421122
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
27. Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000-2014).
Parés-Badell O; Banqué M; Macià F; Castells X; Sala M
Cancer Epidemiol; 2017 Aug; 49():66-74. PubMed ID: 28586708
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a comorbidity scoring system for patients with cirrhosis.
Jepsen P; Vilstrup H; Lash TL
Gastroenterology; 2014 Jan; 146(1):147-56; quiz e15-6. PubMed ID: 24055278
[TBL] [Abstract][Full Text] [Related]
29. Digoxin therapy is not associated with improved survival in epithelial ovarian cancer: A SEER-Medicare database analysis.
Vogel TJ; Jeon C; Karlan B; Walsh C
Gynecol Oncol; 2016 Feb; 140(2):285-8. PubMed ID: 26691221
[TBL] [Abstract][Full Text] [Related]
30. Comorbidities and causes of death in the management of localized T1a kidney cancer.
Patel HD; Kates M; Pierorazio PM; Gorin MA; Jayram G; Ball MW; Hyams ES; Allaf ME
Int J Urol; 2014 Nov; 21(11):1086-92. PubMed ID: 24931430
[TBL] [Abstract][Full Text] [Related]
31. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
[TBL] [Abstract][Full Text] [Related]
32. Predictive ability of Charlson comorbidity index on outcomes from lung cancer.
Ganti AK; Siedlik E; Marr AS; Loberiza FR; Kessinger A
Am J Clin Oncol; 2011 Dec; 34(6):593-6. PubMed ID: 21217398
[TBL] [Abstract][Full Text] [Related]
33. It's contrary - comorbidity does not affect survival of South Africans with colorectal cancer: An analysis from the Colorectal Cancer in South Africa cohort.
Bouter C; Bebington B; Maphosa S; Maher H; Gaylard P; Etheredge HR; Fabian J; Prodehl L; Surridge D; Fourie RL; Harran N; Lutrin D; Bizos D; Ruff P
S Afr Med J; 2020 Apr; 110(5):382-388. PubMed ID: 32657722
[TBL] [Abstract][Full Text] [Related]
34. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
[TBL] [Abstract][Full Text] [Related]
35. Ovarian cancer outcomes: Predictors of early death.
Urban RR; He H; Alfonso R; Hardesty MM; Gray HJ; Goff BA
Gynecol Oncol; 2016 Mar; 140(3):474-80. PubMed ID: 26743531
[TBL] [Abstract][Full Text] [Related]
36. How Is Surgical Risk Best Assessed? A Cohort Comparison of Measures in Total Joint Arthroplasty.
Johnson RL; Habermann EB; Johnson MQ; Abdel MP; Chamberlain AM; Mantilla CB
J Arthroplasty; 2021 Mar; 36(3):851-856.e3. PubMed ID: 33071030
[TBL] [Abstract][Full Text] [Related]
37. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.
Tetsche MS; Dethlefsen C; Pedersen L; Sorensen HT; Norgaard M
BMC Cancer; 2008 Jan; 8():31. PubMed ID: 18230177
[TBL] [Abstract][Full Text] [Related]
38. Characteristics Associated With Receiving Cataract Surgery in the US Medicare and Veterans Health Administration Populations.
Wu AM; Wu CM; Tseng VL; Greenberg PB; Giaconi JA; Yu F; Lum F; Coleman AL
JAMA Ophthalmol; 2018 Jul; 136(7):738-745. PubMed ID: 29800973
[TBL] [Abstract][Full Text] [Related]
39. Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?
Dilley S; Erickson BK; Phillips CE; Kennemer CR; Zhang B; Matin T; Martin JY; Shah MM; Michael Straughn J; Leath CA
Gynecol Oncol; 2018 Apr; 149(1):49-52. PubMed ID: 29605050
[TBL] [Abstract][Full Text] [Related]
40. Development and Validation of the Modified Charlson Comorbidity Index in Incident Peritoneal Dialysis Patients: A National Population-Based Approach.
Cho H; Kim MH; Kim HJ; Park JY; Ryu DR; Lee H; Lee JP; Lim CS; Kim KH; Oh KH; Joo KW; Kim YS; Kim DK
Perit Dial Int; 2017 1-2; 37(1):94-102. PubMed ID: 27605681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]